Pulmonary Function Test

gowshank 32,767 views 67 slides Nov 30, 2012
Slide 1
Slide 1 of 67
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48
Slide 49
49
Slide 50
50
Slide 51
51
Slide 52
52
Slide 53
53
Slide 54
54
Slide 55
55
Slide 56
56
Slide 57
57
Slide 58
58
Slide 59
59
Slide 60
60
Slide 61
61
Slide 62
62
Slide 63
63
Slide 64
64
Slide 65
65
Slide 66
66
Slide 67
67

About This Presentation

No description available for this slideshow.


Slide Content

What exactly are PFTs?
•The term encompasses a wide variety of objective
methods to assess lung function. (Remember that the
primary function is gas exchange).
•Examples include:
–Spirometry
–Pulse oximetry
–Blood gases
–Lung volumes by helium dilution or body plethysmography
–Exercise tests
–Diffusing capacity
–Bronchial challenge testing

Spirometry
•Measurement of the pattern of air
movement into and out of the lungs during
controlled ventilatory maneuvers.
•Often done as a maximal expiratory
maneuver

Importance
•Patients and physicians have inaccurate
perceptions of severity of airflow
obstruction and/or severity of lung disease
by physical exam
•Provides objective evidence in identifying
patterns of disease

Silhouette of Hutchinson
Performing Spirometry
From
Chest,
2002

Indications
•Detect disease
•Evaluate extent and monitor course of
disease
•Evaluate treatment
•Measure effects of exposures
•Assess risk for surgical procedures

contraindications
•Chest or abdominal pain of any cause
•Oral or facial pain exacerbated by
mouthpiece
•Stress incontinence
•Dementia or confused state
•Within one month of Myocardial Infarction

To be avoided
•Smoking- 1 hour
•Alcohol- 4 hour
•Vigorous exercise -30 minutes
•Large meal – 2 hour
•Wearing tight clothes

•Tests should be performed when patients are
clinically stable and free from respiratory infection
• Patients should not have taken:
inhaled short-acting bronchodilators in the
previous six hours
long-acting bronchodilator in the previous 12
hours
sustained-release theophylline in the previous
24 hours

Preparation

Volume Measuring Spirometer

Flow Measuring Spirometer

Desktop Electronic Spirometers

Small Hand-held Spirometers

Weibel ER: Morphometry of the Human
Lung. Berlin and New York: Springer-
Verlag, 1963
The Airways
•Conducting zone: no
gas exchange occurs
–Anatomic dead
space
•Transitional zone:
alveoli appear, but are
not great in number
•Respiratory zone:
contain the alveolar
sacs

From
Netter
Atlas of
Human
Anatomy,
1989

Lung Volumes
IRV
TV
ERV
•4 Volumes
•4 Capacities
–Sum of 2 or
more lung
volumes
RV
IC
FRC
VC
TLC
RV

Tidal Volume (TV)
IRV
TV
ERV
RV
IC
FRC
VC
TLC
RV
•Volume of air
inspired and
expired during
normal quiet
breathing

Inspiratory Reserve Volume (IRV)
IRV
TV
ERV
•The maximum
amount of air
that can be
inhaled after a
normal tidal
volume
inspiration
RV
IC
FRC
VC
TLC
RV

Expiratory Reserve Volume (ERV)
IRV
TV
ERV
•Maximum
amount of air
that can be
exhaled from
the resting
expiratory level
RV
IC
FRC
VC
TLC
RV

Residual Volume (RV)
IRV
TV
ERV
•Volume of air
remaining in the
lungs at the end
of maximum
expiration
RV
IC
FRC
VC
TLC
RV

Vital Capacity (VC)
IRV
TV
ERV
•Volume of air that
can be exhaled
from the lungs
after a maximum
inspiration
•FVC: when VC
exhaled forcefully
•SVC: when VC is
exhaled slowly
•VC = IRV + TV +
ERV
RV
IC
FRC
VC
TLC
RV

Predicted Normal Values
 Age
 Height
 Sex
 Ethnic Origin
Affected by:

Terminology
•Forced vital capacity
(FVC):
–Total volume of air that can
be exhaled forcefully from
TLC
–The majority of FVC can be
exhaled in <3 seconds in
normal people, but often is
much more prolonged in
obstructive diseases
–Measured in liters (L)

FVC
•Interpretation of % predicted:
–80-120% Normal
–70-79% Mild reduction
–50%-69% Moderate reduction
–<50% Severe reduction
FVC

Terminology
•Forced expiratory volume
in 1 second: (FEV
1
)
–Volume of air forcefully
expired from full inflation
(TLC) in the first second
–Measured in liters (L)
–Normal people can exhale
more than 75-80% of their
FVC in the first second;
thus the FEV1/FVC can be
utilized to characterize
lung disease

FEV
1
•Interpretation of % predicted:
–>75% Normal
–60%-75% Mild obstruction
–50-59% Moderate obstruction
–<49% Severe obstruction
FEV
1
FVC

Terminology
•Forced expiratory flow 25-
75% (FEF
25-75
)
–Mean forced expiratory flow
during middle half of FVC
–Measured in L/sec
–May reflect effort
independent expiration and
the status of the small
airways
–Highly variable
–Depends heavily on FVC

FEF
25-75
•Interpretation of % predicted:
–>60% Normal
–40-60% Mild obstruction
–20-40% Moderate obstruction
–<10% Severe obstruction

Standard Spirometric Indicies
•FEV
1
- Forced expiratory volume in one second:
The volume of air expired in the first second of
the blow
•FVC - Forced vital capacity:
The total volume of air that can be forcibly
exhaled in one breath
•FEV
1/FVC ratio:
The fraction of air exhaled in the first second
relative to the total volume exhaled

Criteria for Normal
Post-bronchodilator Spirometry
•FEV
1
: % predicted > 80%
•FVC: % predicted > 80%
•FEV
1
/FVC: > 0.7

Spirometry Interpretation:
Obstructive vs. Restrictive
Defect
•Obstructive Disorders
–FVC nl or↓
–FEV1 ↓
–FEF25-75% ↓
–FEV1/FVC ↓
–TLC nl or ↑
•Restrictive Disorders
–FVC ↓
–FEV1 ↓
–FEF 25-75% nl to ↓
– FEV1/FVC N↑
– TLC ↓

SPIROMETRY
Flow Volume

Flow Volume Curve
•Standard on most desk-top spirometers
•Adds more information than volume
time curve
•Less understood but not too difficult to
interpret
•Better at demonstrating mild airflow
obstruction

Flow Volume Curve
Expiratory
flow rate
L/sec
Volume (L)
FVC
Maximum
expiratory flow
(PEF)
Inspiratory
flow rate
L/sec
RV
TLC

Flow-Volume Loop
•Illustrates maximum
expiratory and
inspiratory flow-
volume curves
•Useful to help
characterize disease
states (e.g.
obstructive vs.
restrictive)
Ruppel GL. Manual of Pulmonary Function Testing, 8
th

ed., Mosby 2003

Normal Trace Showing FEV
1
and
FVC
1 2 3 4 5 6
1
2
3
4
V
o
lu
m
e
, lite
r
s
Time, seconds
FVC5
1
FEV
1
= 4L
FVC = 5L
FEV
1
/FVC = 0.8

Three times FVC within 5% or 0.1 litre (100 ml)
Reproducibility - Quality of Results
V
o
l
u
m
e
,
l
i
t
e
r
s
Time, seconds

Spirogram Patterns
•Normal
•Obstructive
•Restrictive
•Mixed Obstructive and Restrictive

SPIROMETRY
OBSTRUCTIVE
DISEASE

Spirometry: Obstructive Disease
V
o
lu
m
e
, lite
r
s
Time, seconds
5
4
3
2
1
123456
FEV
1
= 1.8L
FVC = 3.2L
FEV
1
/FVC = 0.56
Normal
Obstructive

Flow Volume Curve Patterns
Obstructive and Restrictive
Obstructive Severe obstructive Restrictive
Volume (L)


E
x
p
i
r
a
t
o
r
y

f
l
o
w

r
a
t
e
E
x
p
i
r
a
t
o
r
y

f
l
o
w

r
a
t
e

E
x
p
i
r
a
t
o
r
y

f
l
o
w

r
a
t
e
Volume (L) Volume (L)
Steeple pattern,
reduced peak flow,
rapid fall off
Normal shape,
normal peak flow,
reduced volume
Reduced peak flow,
scooped out mid-
curve

Bronchodilator Reversibility Testing
•Provides the best achievable FEV
1

(and FVC)
•Helps to differentiate COPD from
asthma
Must be interpreted with clinical
history - neither asthma nor COPD
are diagnosed on spirometry alone

Bronchodilator Reversibility
Testing in COPD
Spirometry
•FEV
1
should be measured (minimum twice,
within 5%) before a bronchodilator is given
•The bronchodilator should be given by
metered dose inhaler through a spacer device
or by nebulizer to be certain it has been
inhaled
•The bronchodilator dose should be selected to
be high on the dose/response curve

Bronchodilator Reversibility Testing
in COPD
•An increase in FEV
1
that is both greater
than 200 ml and 12% above the pre-
bronchodilator FEV
1
(baseline value) is
considered significant
•It is usually helpful to report the absolute
change (in ml) as well as the % change from
baseline to set the improvement in a clinical
context

Figure 5.1-6.
Bronchodilator
Reversibility
Testing in COPD
GOLD
Report (2006)

SPIROMETRY
RESTRICTIVE
DISEASE

V
o
lu
m
e
, lite
r
s
Time, seconds
FEV
1
= 1.9L
FVC = 2.0L
FEV
1
/FVC = 0.95
123456
5
4
3
2
1
Spirometry: Restrictive Disease
Normal
Restrictive

Flow Volume Curve Patterns
Obstructive and Restrictive
Obstructive Severe obstructive Restrictive
Volume (L)


E
x
p
i
r
a
t
o
r
y

f
l
o
w

r
a
t
e
E
x
p
i
r
a
t
o
r
y

f
l
o
w

r
a
t
e

E
x
p
i
r
a
t
o
r
y

f
l
o
w

r
a
t
e
Volume (L) Volume (L)
Steeple pattern,
reduced peak flow,
rapid fall off
Normal shape,
normal peak flow,
reduced volume
Reduced peak flow,
scooped out mid-
curve

Mixed Obstructive and Restrictive
V
o
lu
m
e
, lite
r
s
Time, seconds
Restrictive and mixed obstructive-restrictive are difficult to diagnose by
spirometry alone; full respiratory function tests are usually required
(e.g., body plethysmography, etc)
FEV
1
= 0.5L
FVC = 1.5L
FEV
1
/FVC = 0.30
Normal
Obstructive - Restrictive

Spirometry - Quality Control
•Most common cause of inconsistent
readings is poor patient technique
 Sub-optimal inspiration
 Sub-maximal expiratory effort
 Delay in forced expiration
 Shortened expiratory time
 Air leak around the mouthpiece
•Subjects must be observed and
encouraged throughout the procedure

Troubleshooting
Examples - Unacceptable Traces

Unacceptable Trace - Poor Effort
V
o
l
u
m
e
,

l
i
t
e
r
s
Time, seconds
May be accompanied by a slow start
Inadequate sustaining of effort
Variable expiratory effort
Normal

V
o
l
u
m
e
,

l
i
t
e
r
s
Time, seconds
Unacceptable Trace – Stop Early
Normal

V
o
l
u
m
e
,

l
i
t
e
r
s
Time, seconds
Unacceptable Trace – Slow Start
Normal

V
o
l
u
m
e
,

l
i
t
e
r
s
Time, seconds
Unacceptable Trace - Coughing
Normal

V
o
l
u
m
e
,
l
i
t
e
r
s
Time, seconds
Unacceptable Trace – Extra Breath
Normal

EXAMPLE 1
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 4.0 L 3.2 3.2
FVC%(O/P) 80% 80%
FEV1 3.7L 2.9 2.9 +0%- 0ml
FEV1%(O/P) 78% 78%
FEV1/FVC% 90% 90%
PEF 3.51L/S 4.22L/S

EXAMPLE -2
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 2.8L 0.6
FVC%(O/P) 22%
FEV1 2.75L 0.5
FEV1%(O/P) 18.18%
FEV1/FVC% 84%
PEF 5.3L/S 1.6

EXAMPLE 2 cont
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 2.8L 0.6 1.6L
FVC%(O/P) 22% 57%
FEV1 2.75L 0.5 1.0L +100%-500ml
FEV1%(O/P) 18.18% 36.3%
FEV1/FVC% 84% 63%
PEF 5.3L/S 1.6 4.8

EXAMPLE 3
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 2.60L 1.60 1.63
FVC%(O/P) 62% 63%
FEV1 2.17L 1.32 1.34 1.5%-20ml
FEV1%(O/P) 61% 62%
FEV1/FVC% 83% 82%
PEF 5.85L/S 5.34 4.56

EXAMPLE 4
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 2.3L 1.8 1.8
FVC%(O/P) 78% 78%
FEV1 1.95L 0.75 0.75 +0-0ml
FEV1%(O/P) 38% 38%
FEV1/FVC% 41% 41%
PEF 3.10L/s 1.30L/S 1.34L/S

EXAMPLE 5
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 3.22L 1.69 1.82
FVC%(O/P) 52% 56%
FEV1 2.50L 1.15 1.19 +3%
FEV1%(O/P) 46% 48%
FEV1/FVC% 68% 66%
PEF 7.17L/S 4.48 4.41

EXAMPLE 6
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 2.75L 1.1 1.5
FVC%(O/P) 40% 54%
FEV1 2L 0.9 1.0 +11%-100ml
FEV1%(O/P) 31% 46%
FEV1/FVC% 81% 66%
PEF 3.7L/s 1.00L/s 3.20L/s

EXAMPLE 7
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 3.2L 1.54 2.3
FVC%(O/P) 48% 71%
FEV1 2.75L 0.95 1.94 +104%-
990ml
FEV1%(O/P) 34.5% 72%
FEV1/FVC% 61% 69%
PEF 4.50L/s 3L/s 3.70L/s

EXAMPLE 8
TEST PREDICTE
D
BROCHODILATOR CHANGE
BEFORE AFTER
FVC 3.2 L 2.55 2.75
FVC%(O/P) 79% 86%
FEV1 2.75L 1.95 2.3 +18%-
350ml
FEV1%(O/P) 70% 84%
FEV1/FVC% 76% 83%
PEF 4.5L/s 4.00L/s 4.40L/s

gowri